Dividend King Growth Giant: J&J Faces Lilly Challenge
Johnson & Johnson and Eli Lilly reported contrasting Q1 2026 results, pitting a durable, dividend-focused giant again...
Examine the tax effects of rebalancing a portfolio and practical ways to minimize tax impact. This intro covers common scenarios and planning ideas.
21,738 articlesJohnson & Johnson and Eli Lilly reported contrasting Q1 2026 results, pitting a durable, dividend-focused giant again...
If SpaceX ever issued bonds, investors might treat them like junk debt due to high leverage and concentrated revenue....
A deep dive into a sleeper AI infrastructure stock that could gain as data centers demand faster, cleaner connectivit...
The Metals Company stock faced a sharp pullback in early 2026 after a dramatic rally in the previous year. This artic...
Alphabet stock moved higher in a week driven by AI chip ambitions, cloud momentum, and a resilient ad business. This ...
As institutional buyers step into Openlane, individual investors gain a front-row seat to a digitized used-vehicle ma...
Understanding James River (JRVR) earnings means decoding insurance results, investment income, and risk management. T...
A February pullback gave investors a clearer path to big AI winners. Here are three mega-cap picks, plus concrete ste...
When a top executive makes bold moves with his own money, it’s hard not to notice. This article dives into what berks...
A biotech stock surged 75% last quarter and drew a new $9 million investment, signaling confidence from sophisticated...
Evolution Petroleum Corp reaches a historic 50th consecutive quarterly dividend, delivering a 10.6% yield at a $4.50 ...
The Vanguard Health Care ETF has underperformed the broader market by roughly 57 points over five years, yet patient ...